標(biāo)題: Titlebook: NAFLD and NASH; Biomarkers in Detect Manuel Romero-Gomez Book 2020 Springer Nature Switzerland AG 2020 liver fibrosis.elastography.ultrasou [打印本頁] 作者: FERN 時間: 2025-3-21 19:49
書目名稱NAFLD and NASH影響因子(影響力)
書目名稱NAFLD and NASH影響因子(影響力)學(xué)科排名
書目名稱NAFLD and NASH網(wǎng)絡(luò)公開度
書目名稱NAFLD and NASH網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱NAFLD and NASH被引頻次
書目名稱NAFLD and NASH被引頻次學(xué)科排名
書目名稱NAFLD and NASH年度引用
書目名稱NAFLD and NASH年度引用學(xué)科排名
書目名稱NAFLD and NASH讀者反饋
書目名稱NAFLD and NASH讀者反饋學(xué)科排名
作者: 使殘廢 時間: 2025-3-22 00:05 作者: 透明 時間: 2025-3-22 01:04
Jose Tadeu Stefano,Fernanda de Mello Malta,Priscila Brizola de Campos,Pedro Fernandes Andrade,Deniseh gates offer a convenient representation to model the functionality of a reversible circuit but are not universal for quantum operations. Many aspects, particularly those considering fault tolerance and error correction properties, cannot be considered effectively at this abstraction level. Consequ作者: Measured 時間: 2025-3-22 06:48 作者: Sputum 時間: 2025-3-22 12:38
Detection of NAFLD/NASH in the General Population and in Primary Care Clinics,. The association of NAFLD with metabolic morbidity and cardiovascular disease (CVD), as well as its association with significant liver-related morbidity and mortality, create important challenges for primary care physicians in relation to the prevention, diagnosis and treatment of NAFLD and its ass作者: 解脫 時間: 2025-3-22 15:38 作者: 通知 時間: 2025-3-22 19:56
Geometry of Nutrition: Nutrients and NAFLD Progression, the diet’s extent and composition is less known. Thus, it is necessary to establish nutritional guidelines targeting disease mechanisms, improving disease evolution. On the one hand, considering nutrients, foods, meals and diet, macronutrients such as saturated fatty acids, trans-fats, simple sugar作者: Spangle 時間: 2025-3-22 22:22 作者: ALIAS 時間: 2025-3-23 04:29 作者: 承認(rèn) 時間: 2025-3-23 07:24 作者: Sigmoidoscopy 時間: 2025-3-23 10:07 作者: TRAWL 時間: 2025-3-23 15:49
Extracellular Vesicles in Non-alcoholic Fatty Liver Disease: Key Players in Disease Pathogenesis anrming increase in the incidence and prevalence of non-alcoholic fatty liver disease (NAFLD). NAFLD is currently the most prevalent liver disease worldwide, affecting ~25% of the general population. NAFLD is commonly associated with obesity and the metabolic syndrome, and includes a wide spectrum of 作者: 愛管閑事 時間: 2025-3-23 18:16 作者: 現(xiàn)代 時間: 2025-3-23 22:36 作者: ATP861 時間: 2025-3-24 06:16
Psychological Biomarker Profile in NAFLD/NASH with Advanced Fibrosis, the impact of the disease on the patients’ well-being and found an inversely proportional relationship between quality of life and NAFLD severity. The worsening in quality of life is related to the high prevalence of anxiety/depression symptomatology, as well as fatigue and cognitive dysfunction. W作者: Anticoagulant 時間: 2025-3-24 08:25
Integrative Proposal for the Use of Biomarkers in Clinical Practice Management of NAFLD/NASH,m are key issues in the field of liver diseases. While liver biopsy may still be used to diagnose and stage the disease, noninvasive tools (NITs) to appropriately asses the presence of NAFLD and its severity (i.e. presence of NASH) or degree of progression (i.e. presence of advanced fibrosis or cirr作者: Offstage 時間: 2025-3-24 11:35
Book 2020tis (NASH). Basic principles of disease progression, the genetic and nutritional basis of NAFLD and NASH are explained along with the proteomic principles underlying biomarker development. Chapters cover both biochemical and imaging biomarkers used in elastrography and ultrasound and discuss how the作者: 誘導(dǎo) 時間: 2025-3-24 17:45
The Spectrum of NAFLD: From the Organ to the System,an increasing number of studies that support a bidirectional model, in which NAFLD plays a crucial role in the development of metabolic disturbances. Also, there is strong evidence that supports the multisystemic affectation of NAFLD, including cardiovascular, bone and kidney disease, and promoting hepatic and extrahepatic malignancies.作者: Hirsutism 時間: 2025-3-24 20:40
Psychological Biomarker Profile in NAFLD/NASH with Advanced Fibrosis,uding, we approach some treatment-related questions. Lack of therapeutic adherence makes the inclusion of cognitive-behavioral treatment in a multidisciplinary approach to NAFLD highly recommendable. Diffusion of educational and prevention awareness programs on this new twenty-first century pandemic is urgent.作者: Incisor 時間: 2025-3-24 23:30 作者: 象形文字 時間: 2025-3-25 06:49
and ultrasound and discuss how these are applicable to early diagnosis and monitoring of NASH and NAFLD.??. .This is a useful resource for hepatologists, primary care providers with an interest in metabolic disease, diabetologists and endocrinologists in their daily clinical practice..978-3-030-37175-3978-3-030-37173-9作者: 圓木可阻礙 時間: 2025-3-25 09:37 作者: 縱欲 時間: 2025-3-25 14:08
Book 2020se are applicable to early diagnosis and monitoring of NASH and NAFLD.??. .This is a useful resource for hepatologists, primary care providers with an interest in metabolic disease, diabetologists and endocrinologists in their daily clinical practice..作者: 匍匐前進 時間: 2025-3-25 19:03 作者: Keratectomy 時間: 2025-3-25 21:25 作者: BATE 時間: 2025-3-26 02:01 作者: HUSH 時間: 2025-3-26 07:24 作者: 植物學(xué) 時間: 2025-3-26 10:18 作者: 煞費苦心 時間: 2025-3-26 13:04
MR Based-Imaging Biomarkers in NAFLD/NASH, level studies and proton density fat fraction for the quantification of liver fat. The evidence behind these and other MR techniques will be reviewed in this chapter, which aims to provide an overview into the development and clinical applications of MR based biomarkers of NAFLD.作者: 弄臟 時間: 2025-3-26 19:42
Extracellular Vesicles in Non-alcoholic Fatty Liver Disease: Key Players in Disease Pathogenesis anes with important functions in cell-to-cell communication and found in a wide variety of body fluids, are emerging as key players in NAFLD pathogenesis and as promising disease biomarkers. In this chapter, we will focus on the most recent findings concerning the role of EVs as new structures mediati作者: Impugn 時間: 2025-3-27 00:55
HCC in Patients with NAFLD/NASH,apeutic targets. MicroRNAs (miRNAs) play a key role in the pathogenesis of HCC related to NAFLD by closely regulating lipid metabolism, glucose homeostasis, cell proliferation, apoptosis, and cell migration and differentiation. In other words, there are currently no guidelines for the screening and 作者: trigger 時間: 2025-3-27 02:26 作者: Coterminous 時間: 2025-3-27 07:39
Maya Margalit,Hanny Yeshua,Neta Gotlieb,Shira Zelber-Sagi作者: adroit 時間: 2025-3-27 12:25
Ciro Celsa,Grazia Pennisi,Federica Spatola,Aurora Giannetti,Salvatore Petta作者: Arthritis 時間: 2025-3-27 14:41 作者: 數(shù)量 時間: 2025-3-27 20:30
Jesús Funuyet-Salas,Agustín Martín-Rodríguez,Rupert Conrad,María ángeles Pérez-San-Gregorio作者: Annotate 時間: 2025-3-28 01:54
Carlos Benítez,Juan Pablo Arab,Francisco Barrera,Jesus M. Banales,Marco Arrese作者: LIMN 時間: 2025-3-28 06:01
describes testing the quality of generator is using Monobit, Serial and Poker tests. The book then outlines 15 test cases recommended by NIST fifteen test cases, along with their implementation on six evolutionary algorithms for neural cryptographic systems in the context of wireless computations –作者: heartburn 時間: 2025-3-28 09:20
George V. Dedoussis,Athina I. AmanatidouMany algorithms have been proposed to accomplish the first step, i.e., to map an MPMCT circuit to an NCT circuit. In the following section we review the different mapping strategies for MPMCT or ST based circuits. Then, in Sect.?. we introduce an enhanced mapping approach for the ST based circuits. 作者: Parallel 時間: 2025-3-28 13:24 作者: Aromatic 時間: 2025-3-28 18:06
From Transcriptomic to Metabolomic in the Development of Biomarkers in NAFLD/NASH,lex nature behind NAFLD/NASH development. The sum up of all of these omics studies, identified candidate biomarkers that can be an effective tool in the diagnosis and treatment of NAFLD/NASH. The present chapter aims to provide a comprehensive outline of newly published biomarkers resulting from these studies.作者: 喪失 時間: 2025-3-28 20:17
Manuel Romero-GomezPresents most up-to-date information on hepatic biomarkers.Discusses the key methods to detecting Non Alcoholic Steatohepatitis.Reviews both biochemical and imaging biomarkers作者: Entirety 時間: 2025-3-28 23:00 作者: Prosaic 時間: 2025-3-29 05:51
http://image.papertrans.cn/n/image/660015.jpg作者: 烤架 時間: 2025-3-29 07:59
https://doi.org/10.1007/978-3-030-37173-9liver fibrosis; elastography; ultrasound; liver failure; biochemical biomarkers; imaging biomarkers; non-i作者: epicardium 時間: 2025-3-29 13:32
8樓作者: obeisance 時間: 2025-3-29 19:09
8樓作者: 射手座 時間: 2025-3-29 20:51
9樓作者: 空氣 時間: 2025-3-30 02:22
9樓作者: 擴張 時間: 2025-3-30 06:35
9樓作者: 我不死扛 時間: 2025-3-30 09:52
9樓作者: 意外的成功 時間: 2025-3-30 12:30
10樓作者: 妨礙議事 時間: 2025-3-30 19:48
10樓作者: Anthropoid 時間: 2025-3-31 00:08
10樓作者: Mirage 時間: 2025-3-31 01:09
10樓
